Artiva Biotherapeutics, Inc. (ARTV)

NASDAQ

$6.53

$-0.03

(-0.46%)

Regular Market

Artiva Biotherapeutics, Inc. (ARTV) Live Price Chart

Last updated: ⁦2026-10-21 18:49:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Artiva Biotherapeutics, Inc. (ARTV) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $6.53, with a market capitalization of $287.96M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.96 to $14.53. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$287.96M
Open	$6.60
Day's High	$17.31
Day's Low	$1.47
Previous Close	$6.56
Volume	210.27K
Average Volume	408.47K
P/E Ratio	--
52-Week High	$14.53
52-Week Low	$2.96
Dividend Yield	--
Earnings Date	--

Artiva Biotherapeutics, Inc. (ARTV) Stock Price Today

Artiva Biotherapeutics, Inc. (ARTV) is currently trading at $6.53 as of 2026-10-21 18:47:00, down 0.53% ($0.03) from the previous close of $6.56

During today's regular trading session, ARTV has traded between $1.47 and $17.31, with a trading volume of 210.27K shares. The current price is near the lower end of today's range.

Artiva Biotherapeutics, Inc. (ARTV) 7-Day Stock Price Change

Over the past seven days, Artiva Biotherapeutics, Inc. (ARTV) moved from $6.77 to $6.53, representing a decline of 3.62% ($0.24).

The stock traded between $5.76 and $6.94 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 503.07 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

ARTV 52-Week Price Position

Position in Range: 30.8%

52W Low$2.96

52W High$14.53

ARTV is currently trading at $6.53, placing it 30.8% of the way from its 52-week low of $2.96 to its 52-week high of $14.53. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Artiva Biotherapeutics, Inc. (ARTV)?

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).

Artiva Biotherapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	115
Exchange	NASDAQ
Company Website	https://www.artivabio.com

How to Buy Artiva Biotherapeutics, Inc. (ARTV) Stock on MEXC

Eligible investors can buy real shares of Artiva Biotherapeutics, Inc. (ARTV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ARTV and Place Your Order

Open the RealStocks trading page and search for ARTV. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Artiva Biotherapeutics, Inc. (ARTV) stock price today?

Artiva Biotherapeutics, Inc. (ARTV) is currently trading at $ 6.53, down 0.53% ($0.03) from the previous close of $ 6.56. Intraday prices update in real time during regular trading hours.

2.Is ARTV stock going up or down today?

As of 2026-10-21 18:47:00, ARTV is trading at $ 6.53, down 0.53% ($0.03) from its previous close of $ 6.56. The stock has traded between $ 1.47 and $ 17.31 during today’s regular session. Past price movements do not guarantee future results.

3.What is ARTV pre-market price?

As of 2026-10-21 18:47:00, ARTV is trading at $ 6.59 in pre-market trading, up 0.38% ($0.03) from the previous close of $ 6.56. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ARTV after-hours price?

As of 2026-10-21 18:47:00, ARTV is trading at $ 6.59 in after-hours trading, up 0.38% ($0.03) from the regular-session close of $ 6.56. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ARTV stock trading now?

ARTV trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ARTV sit relative to its 52-week high and low?

Over the past 52 weeks, ARTV has traded between a low of $ 2.96 and a high of $ 14.53. At $ 6.53, the stock is positioned 30.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Artiva Biotherapeutics, Inc. in?

Artiva Biotherapeutics, Inc. (ARTV) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Artiva Biotherapeutics, Inc.'s market capitalization and where is it listed?

Artiva Biotherapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 287.96M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ARTV valued in terms of P/E ratio and EPS?

ARTV trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.86. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Artiva Biotherapeutics, Inc. pay a dividend?

Artiva Biotherapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.